Get started
Red Light Holland CorpRed Light Holland CorpRed Light Holland Corp

Red Light Holland Corp

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsSeasonals

Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Earnings
2026
Earnings, Q4 FY2026
Jul 29, 2026
Filament acquisition and rebrand drive focus on psychedelic drug innovation amid revenue decline.
Earnings, Q3 FY2026
Mar 3, 2026
Q3 2026 revenue up 8.3% year-over-year, with R&D focus and asset sales amid industry shifts.
Earnings, Q2 FY2026
Nov 30, 2025
Revenue and profit fell sharply, but strong cash and R&D focus support future growth.
Earnings, Q1 FY2026
Aug 27, 2025
Revenue declined and losses widened, but strategic expansion and innovation continued.
2025
Earnings, Q4 FY2025
Jul 30, 2025
Revenue up, losses down, and strategic pivots set the stage for sustainable growth.